220 related articles for article (PubMed ID: 34020641)
1. Effect of different corticosteroid regimes for hospitalised patients with exacerbated COPD: pooled analysis of individual participant data from the REDUCE and CORTICO-COP trials.
Sivapalan P; Rutishauser J; Ulrik CS; Leuppi JD; Pedersen L; Mueller B; Eklöf J; Biering-Sørensen T; Gottlieb V; Armbruster K; Janner J; Moberg M; Lapperre TS; Nielsen TL; Browatzki A; Mathioudakis A; Vestbo J; Schüetz P; Jensen JU
Respir Res; 2021 May; 22(1):155. PubMed ID: 34020641
[TBL] [Abstract][Full Text] [Related]
2. Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease.
Walters JA; Tan DJ; White CJ; Wood-Baker R
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD006897. PubMed ID: 29553157
[TBL] [Abstract][Full Text] [Related]
3. Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease.
Walters JA; Tan DJ; White CJ; Wood-Baker R
Cochrane Database Syst Rev; 2014 Dec; (12):CD006897. PubMed ID: 25491891
[TBL] [Abstract][Full Text] [Related]
4. Reduction of corticosteroid use in outpatient treatment of exacerbated COPD - Study protocol for a randomized, double-blind, non-inferiority study, (The RECUT-trial).
Urwyler P; Boesing M; Abig K; Cattaneo M; Dieterle T; Zeller A; Bachler H; Markun S; Senn O; Merlo C; Essig S; Ullmer E; Rutishauser J; Schuurmans MM; Leuppi JD
Trials; 2019 Dec; 20(1):727. PubMed ID: 31842993
[TBL] [Abstract][Full Text] [Related]
5. Eosinophil-guided corticosteroid therapy in patients admitted to hospital with COPD exacerbation (CORTICO-COP): a multicentre, randomised, controlled, open-label, non-inferiority trial.
Sivapalan P; Lapperre TS; Janner J; Laub RR; Moberg M; Bech CS; Eklöf J; Holm FS; Armbruster K; Sivapalan P; Mosbech C; Ali AKM; Seersholm N; Wilcke JT; Brøndum E; Sonne TP; Rønholt F; Andreassen HF; Ulrik CS; Vestbo J; Jensen JS
Lancet Respir Med; 2019 Aug; 7(8):699-709. PubMed ID: 31122894
[TBL] [Abstract][Full Text] [Related]
6. Corticosteroids in the treatment of acute exacerbations of chronic obstructive pulmonary disease.
Woods JA; Wheeler JS; Finch CK; Pinner NA
Int J Chron Obstruct Pulmon Dis; 2014; 9():421-30. PubMed ID: 24833897
[TBL] [Abstract][Full Text] [Related]
7. Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT.
Devereux G; Cotton S; Fielding S; McMeekin N; Barnes PJ; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; Soyza A; Gompertz S; Haughney J; Innes K; Kaniewska J; Lee A; Morice A; Norrie J; Sullivan A; Wilson A; Price D
Health Technol Assess; 2019 Jul; 23(37):1-146. PubMed ID: 31343402
[TBL] [Abstract][Full Text] [Related]
8. Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease.
Walters JA; Wang W; Morley C; Soltani A; Wood-Baker R
Cochrane Database Syst Rev; 2011 Oct; (10):CD006897. PubMed ID: 21975757
[TBL] [Abstract][Full Text] [Related]
9. A multi-center randomized, controlled, open-label trial evaluating the effects of eosinophil-guided corticosteroid-sparing therapy in hospitalised patients with COPD exacerbations - The CORTICO steroid reduction in COPD (CORTICO-COP) study protocol.
Sivapalan P; Moberg M; Eklöf J; Janner J; Vestbo J; Laub RR; Browatzki A; Armbruster K; Wilcke JT; Seersholm N; Weinreich UM; Titlestad IL; Andreassen HF; Ulrik CS; Bødtger U; Nielsen TL; Hansen EF; Jensen JUS
BMC Pulm Med; 2017 Aug; 17(1):114. PubMed ID: 28810909
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of medical expenditure with nebulized budesonide versus systemic corticosteroids in hospitalized patients with acute exacerbations of chronic obstructive pulmonary disease in China.
Zhang J; Yao W; You X; Liu T; Liu Y
Int J Chron Obstruct Pulmon Dis; 2019; 14():1195-1207. PubMed ID: 31213797
[No Abstract] [Full Text] [Related]
11. Impact of corticosteroids on the duration of ventilatory support during severe acute exacerbations of chronic obstructive pulmonary disease in patients in the intensive care unit: a study protocol for a multicentre, randomized, placebo-controlled, double-blind trial.
Ferré A; Thille AW; Mekontso-Dessap A; Similowski T; Legriel S; Aegerter P; Demoule A;
Trials; 2023 Mar; 24(1):231. PubMed ID: 36967375
[TBL] [Abstract][Full Text] [Related]
12. Antibiotics for exacerbations of chronic obstructive pulmonary disease.
Vollenweider DJ; Jarrett H; Steurer-Stey CA; Garcia-Aymerich J; Puhan MA
Cochrane Database Syst Rev; 2012 Dec; 12():CD010257. PubMed ID: 23235687
[TBL] [Abstract][Full Text] [Related]
13. Exacerbation recovery patterns in newly diagnosed or maintenance treatment-naïve patients with COPD: secondary analyses of TICARI 1 trial data.
Mannino DM; Clerisme-Beaty EM; Franceschina J; Ting N; Leidy NK
Int J Chron Obstruct Pulmon Dis; 2018; 13():1515-1525. PubMed ID: 29785101
[TBL] [Abstract][Full Text] [Related]
14. Extended Versus Short-Course Corticosteroid Taper Regimens in the Management of Chronic Obstructive Pulmonary Disease Exacerbations in Critically Ill Patients.
Poon T; Paris DG; Aitken SL; Patrawalla P; Bondarsky E; Altshuler J
J Intensive Care Med; 2020 Mar; 35(3):257-263. PubMed ID: 29161935
[TBL] [Abstract][Full Text] [Related]
15. Bone turnover biomarkers in COPD patients randomized to either a regular or shortened course of corticosteroids: a substudy of the randomized controlled CORTICO-COP trial.
Sivapalan P; Jørgensen NR; Mathioudakis AG; Eklöf J; Lapperre T; Ulrik CS; Andreassen HF; Armbruster K; Sivapalan P; Janner J; Godtfredsen N; Weinreich UM; Nielsen TL; Seersholm N; Wilcke T; Schuetz P; Klausen TW; Marså K; Vestbo J; Jensen JU
Respir Res; 2020 Oct; 21(1):263. PubMed ID: 33046053
[TBL] [Abstract][Full Text] [Related]
16. Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD.
Postma DS; Roche N; Colice G; Israel E; Martin RJ; van Aalderen WM; Grigg J; Burden A; Hillyer EV; von Ziegenweidt J; Gopalan G; Price D
Int J Chron Obstruct Pulmon Dis; 2014; 9():1163-86. PubMed ID: 25378918
[TBL] [Abstract][Full Text] [Related]
17. Doxycycline for outpatient-treated acute exacerbations of COPD: a randomised double-blind placebo-controlled trial.
van Velzen P; Ter Riet G; Bresser P; Baars JJ; van den Berg BTJ; van den Berg JWK; Brinkman P; Dagelet JWF; Daniels JMA; Groeneveld-Tjiong DRGL; Jonkers RE; van Kan C; Krouwels FH; Pool K; Rudolphus A; Sterk PJ; Prins JM
Lancet Respir Med; 2017 Jun; 5(6):492-499. PubMed ID: 28483402
[TBL] [Abstract][Full Text] [Related]
18. Predictors of re-exacerbation after an index exacerbation of chronic obstructive pulmonary disease in the REDUCE randomised clinical trial.
Engel B; Schindler C; Leuppi JD; Rutishauser J
Swiss Med Wkly; 2017; 147():w14439. PubMed ID: 28634972
[TBL] [Abstract][Full Text] [Related]
19. Systemic corticosteroid for COPD exacerbations, whether the higher dose is better? A meta-analysis of randomized controlled trials.
Cheng T; Gong Y; Guo Y; Cheng Q; Zhou M; Shi G; Wan H
Clin Respir J; 2013 Oct; 7(4):305-18. PubMed ID: 23072733
[TBL] [Abstract][Full Text] [Related]
20. Multicentre double-blind randomised controlled trial of systematic corticosteroid therapy in patients with acute exacerbations of chronic obstructive pulmonary disease admitted to hospital with higher eosinophil levels: the ECHO protocol.
Liang L; Lin Y; Feng L; Shao S; Cao S; Rong H; Chu S; Xie W; Cai S; Wang J; Tong Z
BMJ Open; 2023 May; 13(5):e066354. PubMed ID: 37247957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
